Abstract
Objective:
Weight regain contributes to the therapeutic failure in 15–20% of type 2 diabetic patients after Roux-en-Y gastric bypass surgery (RYGB), and the mechanism remains largely unknown. This study was conducted to explore the mechanism of weight regain.
Research design:
Wild-type (WT) diet-induced obese (DIO) mice were used to mimic human obesity, and ob/ob mice were used for leptin deficiency-induced obesity. Two groups of mice were compared in weight regain for 10 months after RYGB. Weight loss, food intake, fecal energy loss and energy expenditure were monitored in the study of weight regain. Fasting insulin, insulin tolerance and homeostatic model assessment-insulin resistance were tested for insulin sensitivity under the weight regain. Weight loss from RYGB and calorie restriction was compared for the impact in insulin sensitivity.
Results:
In WT mice, RYGB induced a sustained weight loss and insulin sensitization over the sham operation in this 10-month study. However, RYGB failed to generate the same effects in leptin-deficient ob/ob mice, which suffered a weight regain over the pre-surgery level. In ob/ob mice, body weight was reduced by RYGB transiently in the first week, recovered in the second week and increased over the baseline thereafter. Weight loss was induced by RYGB relative to that of sham mice, but the loss was not sufficient to keep body weight below the pre-surgery levels. In addition, insulin sensitivity was not improved by the weight loss. The response to RYGB was improved in ob/ob mice by 2 weeks of leptin treatment. Weight loss from calorie restriction had an equivalent effect on insulin sensitization compared with that of RYGB.
Conclusion:
Those data demonstrate that ob/ob mice and DIO mice responded differently to RYGB surgery, suggesting that leptin may be one of the factors required for RYGB to prevent weight regain and diabetes recurrence.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724–1737.
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD et al. Bariatric surgery versus intensive medical therapy for diabetes - 3-year outcomes. N Engl J Med 2014; 370: 2002–2013.
Coll AP, Farooqi IS, O'Rahilly S . The hormonal control of food Intake. Cell 2007; 129: 251–262.
Stefater MA, Wilson-Perez HE, Chambers AP, Sandoval DA, Seeley RJ . All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev 2012; 33: 595–622.
Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004; 240: 236–242.
Laferrere B, Heshka S, Wang K, Khan Y, McGinty J, Teixeira J et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007; 30: 1709–1716.
Korner J, Inabnet W, Conwell IM, Taveras C, Daud A, Olivero-Rivera L et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring) 2006; 14: 1553–1561.
Chandarana K, Gelegen C, Karra E, Choudhury AI, Drew ME, Fauveau V et al. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. Diabetes 2011; 60: 810–818.
Cummings DE, Overduin J, Foster-Schubert KE . Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004; 89: 2608–2615.
Ye J, Hao Z, Mumphrey MB, Townsend RL, Patterson LM, Stylopoulos N et al. GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. Am J Physiol Regul Integr Comp Physiol 2014; 306: R352–R362.
Mokadem M, Zechner JF, Margolskee RF, Drucker DJ, Aguirre V . Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency. Mol Metab 2013; 3: 191–201.
Chambers AP, Jessen L, Ryan KK, Sisley S, Wilson-Perez HE, Stefater MA et al. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology 2011; 141: 950–958.
Abegg K, Schiesser M, Lutz TA, Bueter M . Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass. Physiol Behav 2013; 121: 70–78.
Wilson-Perez HE, Chambers AP, Sandoval DA, Stefater MA, Woods SC, Benoit SC et al. The effect of vertical sleeve gastrectomy on food choice in rats. Int J Obes (Lond) 2013; 37: 288–295.
Stefater MA, Perez-Tilve D, Chambers AP, Wilson-Perez HE, Sandoval DA, Berger J et al. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology 2010; 138: 2426–2436 2436 e1-3.
Grayson BE, Schneider KM, Woods SC, Seeley RJ . Improved rodent maternal metabolism but reduced intrauterine growth after vertical sleeve gastrectomy. Science Transl Med 2013; 5: 199ra112.
Bjorbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS . Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998; 1: 619–625.
Shin AC, Zheng H, Townsend RL, Sigalet DL, Berthoud HR . Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 2010; 151: 1588–1597.
Xu Y, Ohinata K, Meguid MM, Marx W, Tada T, Chen C et al. Gastric bypass model in the obese rat to study metabolic mechanisms of weight loss. J Surg Res 2002; 107: 56–63.
Meirelles K, Ahmed T, Culnan DM, Lynch CJ, Lang CH, Cooney RN . Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann Surg 2009; 249: 277–285.
Hao Z, Zhao Z, Berthoud H-R, Ye J . Development and erification of a mouse model for Roux-en-Y gastric bypass surgery with a small gastric pouch. PLoS One 2013; 8: e52922.
Tang T, Zhang J, Yin J, Staszkiewicz J, Gawronska-Kozak B, Mynatt R et al. Uncoupling of inflammation and insulin resistance by NF-kB in transgenic mice through induction of energy expenditure. J Biol Chem 2010; 285: 4637–4644.
Bouret SG, Draper SJ, Simerly RB . Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 2004; 304: 108–110.
Vaisse C, Halaas JL, Horvath CM, Darnell JE Jr, Stoffel M, Friedman JM . Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 1996; 14: 95–97.
Harris RB, Zhou J, Redmann SM Jr, Smagin GN, Smith SR, Rodgers E et al. A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. Endocrinology 1998; 139: 8–19.
Isbell JM, Tamboli RA, Hansen EN, Saliba J, Dunn JP, Phillips SE et al. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care 2010; 33: 1438–1442.
Jackness C, Karmally W, Febres G, Conwell IM, Ahmed L, Bessler M et al. Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and beta-cell function in type 2 diabetic patients. Diabetes 2013; 62: 3027–3032.
Lingvay I, Guth E, Islam A, Livingston E . Rapid improvement of diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes Care 2013; 36: 2741–2747.
Buch TR, Heling D, Damm E, Gudermann T, Breit A . Pertussis toxin-sensitive signaling of melanocortin-4 receptors in hypothalamic GT1-7 cells defines agouti-related protein as a biased agonist. J Biol Chem 2009; 284: 26411–26420.
Farooqi S, O'Rahilly S . Genetics of obesity in humans. Endocr Rev 2006; 27: 710–718.
Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S . Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085–1095.
Hatoum IJ, Stylopoulos N, Vanhoose AM, Boyd KL, Yin DP, Ellacott KL et al. Melanocortin-4 receptor signaling Is required for weight loss after gastric bypass surgery. J Clin Endocrinol Metab 2012; 97: E1023–E1031.
Zechner JF, Mirshahi UL, Satapati S, Berglund ED, Rossi J, Scott MM et al. Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans. Gastroenterology 2013; 144: 580–590 e7.
Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 2014; 509: 183–188.
Saeidi N, Meoli L, Nestoridi E, Gupta NK, Kvas S, Kucharczyk J et al. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science 2013; 341: 406–410.
Acknowledgements
This study is supported by the National Institutes of Health research projects DK085495 and DK068036 (ZH and JY), DK047348 (HRB), DK072476 (HM), F32-DK097896 (KRZ), COBRE (NIH P20-RR021945) and CNRU (NIH 1P30-DK072476) center grants (Cell Biology and Bio-imaging Core facilities).
Author Contributions
ZH, KR-Z, CD, RAM and HL, performed the experiments. HM, MK, H-RB and JY designed the study and wrote the manuscript. JY is fully responsible for this article. All authors read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Hao, Z., Münzberg, H., Rezai-Zadeh, K. et al. Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery. Int J Obes 39, 798–805 (2015). https://doi.org/10.1038/ijo.2014.189
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2014.189
This article is cited by
-
Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Roux-en-Y Gastric Bypass Outcomes: a 15-Year Case–Control Study
Obesity Surgery (2022)
-
Pre-operative Predictors of Weight Loss and Weight Regain Following Roux-en-Y Gastric Bypass Surgery: a Prospective Human Study
Obesity Surgery (2020)
-
Body weight-dependent and independent improvement in lipid metabolism after Roux-en-Y gastric bypass in ApoE*3Leiden.CETP mice
International Journal of Obesity (2019)
-
Serum IGF-binding protein 2 (IGFBP-2) concentrations change early after gastric bypass bariatric surgery revealing a possible marker of leptin sensitivity in obese subjects
Endocrine (2019)
-
Regulated expression of Gemin5, Xrn1, Cpeb and Stau1 in the uterus and ovaries after superovulation and the effect of exogenous estradiol and leptin in rodents
Molecular Biology Reports (2019)